Safeguards in blood supply: A National and European challenge

Transfusion Medicine and Hemotherapy

Volumn 37, Issue 3, 2010, Pages 109-110

  Frey, Beat M ^a   Schlenke, Peter ^b  

^a Blood Transfusion Service SRC   (Switzerland)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD DONOR; BLOOD TRANSFUSION; EDITORIAL; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NUCLEIC ACID AMPLIFICATION; QUALITY CONTROL; SAFETY; SCREENING TEST; VOLUNTEER;

EID: 77953788960     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315041     Document Type: Editorial

References (7)

1. Seitz R, Heiden M: Quality and safety in blood supply. Transfus Med Hemother 2010;37(3):112-117.
2. Roth WK: Quarantine plasma: quo vadis? Transfus Med Hemother 2010;37(3):118-122.
3. Offergeld R, Hamouda O, Burger R: Epidemiological data - an important part of the hemovigilance system. Transfus Med Hemother 2010;37(3): 125-130.
4. Katalinic A, Peters E, Beske F, Pritzkuleit R: Projection of morbidity 2030 and 2050: impact for the national health system and blood supply. Transfus Med Hemother 2010;37(3):155-159.
5. Ehling M, Pötzsch O: Demographic changes in Germany up to 2060 - consequences for blood donation. Transfus Med Hemother 2010;37(3): 131-139.
6. Greinacher A, Fendrich K, Hoffmann W: Demographic changes: the impact for safe blood supply. Transfus Med Hemother 2010;37(3):141-148.
7. Goette L, Stutzer A, Frey BM: Prosocial motivation and blood donations: a survey of the empirical literature. Transfus Med Hemother 2010;37(3): 149-154.